NO305599B1 - Nye krystallformer av vannfritt 7-([1<alfa>,5<alfa>,6<alfa>]-6-amino-3-azabicyklo [3.1.0] heks-3-yl)-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt, fremgangsmÕte ved fremstilling derav og farm - Google Patents

Nye krystallformer av vannfritt 7-([1<alfa>,5<alfa>,6<alfa>]-6-amino-3-azabicyklo [3.1.0] heks-3-yl)-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt, fremgangsmÕte ved fremstilling derav og farm

Info

Publication number
NO305599B1
NO305599B1 NO962321A NO962321A NO305599B1 NO 305599 B1 NO305599 B1 NO 305599B1 NO 962321 A NO962321 A NO 962321A NO 962321 A NO962321 A NO 962321A NO 305599 B1 NO305599 B1 NO 305599B1
Authority
NO
Norway
Prior art keywords
alpha
naphthyridine
azabicyclo
difluorophenyl
hex
Prior art date
Application number
NO962321A
Other languages
English (en)
Other versions
NO962321D0 (no
NO962321L (no
Inventor
Lynne A Handanyan
Robert L Hendrickson
Phillip J Johnson
Thomas A Morris
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO962321D0 publication Critical patent/NO962321D0/no
Publication of NO962321L publication Critical patent/NO962321L/no
Publication of NO305599B1 publication Critical patent/NO305599B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO962321A 1995-06-06 1996-06-05 Nye krystallformer av vannfritt 7-([1<alfa>,5<alfa>,6<alfa>]-6-amino-3-azabicyklo [3.1.0] heks-3-yl)-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt, fremgangsmÕte ved fremstilling derav og farm NO305599B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (3)

Publication Number Publication Date
NO962321D0 NO962321D0 (no) 1996-06-05
NO962321L NO962321L (no) 1996-12-09
NO305599B1 true NO305599B1 (no) 1999-06-28

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962321A NO305599B1 (no) 1995-06-06 1996-06-05 Nye krystallformer av vannfritt 7-([1<alfa>,5<alfa>,6<alfa>]-6-amino-3-azabicyklo [3.1.0] heks-3-yl)-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt, fremgangsmÕte ved fremstilling derav og farm

Country Status (38)

Country Link
US (1) US5763454A (no)
EP (1) EP0789697B1 (no)
JP (1) JP3145715B2 (no)
KR (1) KR100191989B1 (no)
CN (1) CN1055474C (no)
AR (1) AR002753A1 (no)
AU (1) AU703634B2 (no)
BG (1) BG62443B1 (no)
BR (1) BR9602630A (no)
CA (1) CA2223404C (no)
CZ (1) CZ285878B6 (no)
DE (1) DE69503066T2 (no)
DK (1) DK0789697T3 (no)
DZ (1) DZ2046A1 (no)
ES (1) ES2117426T3 (no)
FI (1) FI974441A0 (no)
HR (1) HRP960267B1 (no)
HU (1) HUP9601540A3 (no)
IL (1) IL118488A (no)
IS (1) IS4351A (no)
LV (1) LV11619B (no)
MA (1) MA23892A1 (no)
NO (1) NO305599B1 (no)
NZ (1) NZ286735A (no)
OA (1) OA10293A (no)
PE (1) PE38097A1 (no)
PL (1) PL314604A1 (no)
RU (1) RU2125571C1 (no)
SG (1) SG54339A1 (no)
SI (1) SI9600185A (no)
SK (1) SK280535B6 (no)
TN (1) TNSN96084A1 (no)
TW (2) TW580389B (no)
UA (1) UA44718C2 (no)
UY (1) UY25459A1 (no)
WO (1) WO1996039406A1 (no)
YU (1) YU34596A (no)
ZA (1) ZA964647B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
DE19800214A1 (de) * 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (es) 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
TWI608970B (zh) * 2013-01-11 2017-12-21 參天製藥股份有限公司 內塞和具備該內塞的液體收容容器、以及注口的前端構造和具備該構造的液體收容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
KR100221386B1 (ko) * 1994-01-18 1999-09-15 디. 제이. 우드, 스피겔 알렌 제이 나프티리돈카복실산 염의 제조방법 및 중간체
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
MA23892A1 (fr) 1996-12-31
HU9601540D0 (en) 1996-07-29
UA44718C2 (uk) 2002-03-15
DE69503066T2 (de) 1998-10-15
ZA964647B (en) 1997-10-22
MX9709873A (es) 1998-03-31
DE69503066D1 (de) 1998-07-23
LV11619B (en) 1997-04-20
HUP9601540A2 (en) 1997-02-28
NZ286735A (en) 1998-01-26
SK280535B6 (sk) 2000-03-13
ES2117426T3 (es) 1998-08-01
UY25459A1 (es) 1999-11-17
RU2125571C1 (ru) 1999-01-27
WO1996039406A1 (en) 1996-12-12
FI974441A (fi) 1997-12-05
CN1055474C (zh) 2000-08-16
SG54339A1 (en) 1998-11-16
HRP960267B1 (en) 2000-06-30
IL118488A0 (en) 1996-09-12
HUP9601540A3 (en) 1997-05-28
CN1148596A (zh) 1997-04-30
CA2223404A1 (en) 1996-12-12
AU703634B2 (en) 1999-03-25
BR9602630A (pt) 1998-09-08
AR002753A1 (es) 1998-04-29
BG62443B1 (bg) 1999-11-30
IS4351A (is) 1996-12-07
PL314604A1 (en) 1996-12-09
HRP960267A2 (en) 1997-08-31
SK71996A3 (en) 1997-03-05
AU5474996A (en) 1996-12-19
KR970001352A (ko) 1997-01-24
PE38097A1 (es) 1997-10-10
JP3145715B2 (ja) 2001-03-12
US5763454A (en) 1998-06-09
TNSN96084A1 (fr) 2005-03-15
DK0789697T3 (da) 1998-10-19
KR100191989B1 (ko) 1999-06-15
JPH10506650A (ja) 1998-06-30
FI974441A0 (fi) 1997-12-05
CA2223404C (en) 2001-01-16
OA10293A (en) 1997-09-19
TW580389B (en) 2004-03-21
TW403751B (en) 2000-09-01
CZ162596A3 (cs) 1998-09-16
NO962321D0 (no) 1996-06-05
BG100639A (bg) 1997-02-28
SI9600185A (en) 1997-04-30
LV11619A (lv) 1996-12-20
DZ2046A1 (fr) 2002-10-22
YU34596A (sh) 1999-03-04
EP0789697A1 (en) 1997-08-20
NO962321L (no) 1996-12-09
CZ285878B6 (cs) 1999-11-17
EP0789697B1 (en) 1998-06-17
IL118488A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
NO305599B1 (no) Nye krystallformer av vannfritt 7-([1&lt;alfa&gt;,5&lt;alfa&gt;,6&lt;alfa&gt;]-6-amino-3-azabicyklo [3.1.0] heks-3-yl)-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt, fremgangsmÕte ved fremstilling derav og farm
MA23354A1 (fr) Amide tricyclique et composes d&#39;uree utiles pour l&#39;hinibition de la fonction proteine g.
NO175531C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazo(4,5-b)-kinolinyloksyalkansyreamider
CA2173963A1 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
NO176605C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 7-(1-azetidinyl)-1,4-dihydro-4-okso-3-kinolinkarboksylsyrederivater
DE69434773D1 (de) Vorrichtung zur schnellen thermischen Behandlung zur Herstellung von Halbleiterwafern
NO174891C (no) Analogifremgangsmåt ved fremstilling av terapeutisk aktive substituerte pyrroler
NO175530C (no) Fremgangsmåte for fremstilling av 1H-imidazo(4,5-c)- kinoliner, og mellomprodukter derfor
NO308465B1 (no) FremgangsmÕte for fremstilling av karboksylsyrederivater
NO305838B1 (no) FremgangsmÕte og mellomprodukter for fremstilling av naftyridonkarboksylsyresalter
HUP0200006A3 (en) Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8-diazabicyclo - [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid process for their preparation, pharmaceutical composition comprising thereof and their use
NO870482D0 (no) Fremgangsmaate ved fremstilling av nye karboksylsyreamider.
NO20014059L (no) Krystallmodifikasjon D av 8-cyano-1-cyklopropyl-7-(1S,6S-2,8- diazabicyklo-/4.3.0/-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyre
ATE167478T1 (de) Kristallform von wasserfreien 7-((1a,5a,6a)-6- amino-3-azabicyclo (3.1.0.) hex-3-yl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8- naphthyridin-carbonsäure methanesulfonsäure salz
AP9600851A0 (en) Novel crystal form of anhydrous 7-(1A,5A,6A) -6- amino-3- azabicyclo(3.1.0)hex-3-YL) -6- fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo1,8-naphthyridine S-3-carboxylic acid methanesulfonic acid salt
NO891919L (no) Fremgangsmaate for fremstilling av nye karboksylsyrederivater.
MX9708562A (es) Metodo para hacer acidos carboxilicos quinolone o acidos carboxilicos naftiridina en forma de base libre.
NO923114D0 (no) Heterocykliske karboksylsyreestere, fremgangsmaater for fremstilling av dem og anvendelse av dem for fremstilling avgastro-intestinale medisiner
NO20014449L (no) Fremgangsmåte for fremstilling av 5-amino-8- alkylkinolonkarboksylsyrederivater og mellomprodukter ifremstillingen derav
NO20012101L (no) Fremgangsmåte for fremstilling av &lt;alfa&gt;-arylalkansyrer
EA200100830A1 (ru) Производные 4-аминохиназолина и хинолина, оказывающие ингибирующее действие на преобразование сигнала, опосредованное тирозинкиназой

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees